Radiology Doctors in Williston, ND Accepting Medicare

4 Radiology doctors found. Showing 1 - 4

Dr. Glenn P Moradian, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1301 15th Ave W, Williston, ND 58801 Phone: 701-774-7401

Dr. Leszek J Jaszczak, M.D. Radiology - Diagnostic Radiology Medicare: May Accept Medicare Assignments Practice Location: 3 4th St E, Suite 201, Williston, ND 58801 Phone: 701-577-6337

Madhusudhan P Reddy, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1301 15th Ave. W., Williston, ND 58801 Phone: 701-774-7400    Fax: 701-774-7479

Mark R Krakovitz, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1301 15th Ave. W., Williston, ND 58801 Phone: 701-774-7435    Fax: 701-774-7479

News Archive

DuoCort Pharma granted marketing authorization for adrenal insufficiency drug, Plenadren in Europe

The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.

Shire starts two adult ADHD outreach programs

Shire plc today announced two initiatives reinforcing their commitment to the care of adults with Attention-Deficit/Hyperactivity Disorder (ADHD), a psychiatric behavioral disorder that affects an estimated 10 million adults across the country.

Results of Phase I ThermoDox dose escalation trial to be discussed in a press conference

Celsion Corporation today announced that Dr. Ronnie T.P. Poon from the University of Hong Kong and lead principal investigator for the Asia Pacific region of the Phase I ThermoDox dose escalation trial will hold a press conference on Thursday, April 15, 2010 at 10:30 AM HKT (Wednesday, April 14, 2010 10:30 PM ET) to discuss the long-term follow-up of patients treated from April 2006 to December 2006.

Glythera secures £700k to advance development of new generation of biological therapeutics

Glythera Ltd is delighted to announce that it has successfully achieved a number of technical and commercial milestones which has resulted in the release of a second tranche of funding totalling £700k from IP Group and its managed fund, the Finance for Business North East Technology Fund.

Read more Medical News

› Verified 5 days ago